Sign in

CIK 0001757499 · <br>Emerging growth company

Shuttle Pharmaceuticals Holdings, Inc.

Sign in to watch
Ticker
SHPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(240) 403-4212
Business address
401 PROFESSIONAL DRIVE, SUITE 260, GAITHERSBURG, MD, 20879
Former names
Shuttle Pharmaceuticals Holdings, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-12-13 Jacobs Bette Director Sale −4,157 $0.46 $2K 27,064
2023-08-14 Dritschilo Anatoly CEO and Chairman Gift −2,100,000 1,104,407
2023-08-14 Dritschilo Anatoly CEO and Chairman Gift +2,100,000 2,100,000
2023-02-15 Brown Milton Director Grant or award · Stock Options +25,000 25,000
2022-12-29 Senanayake Chris Director Sale −1,626 $1.61 $3K 2,791
2022-12-29 Richards Steven M Director Sale −995 $1.61 $2K 1,707
2022-12-29 Adkins William Former Director Sale −995 $1.61 $2K 184,071
2022-12-29 Brown Milton Director Sale −995 $1.61 $2K 1,072,531
2022-12-29 Dritschilo Anatoly CEO and Chairman Sale −8,372 $1.61 $13K 1,085,200
2022-12-29 Rich Tyvin Chief Medical Officer Sale −1,414 $1.61 $2K 2,429
2022-12-29 Jung Mira Chief Scientific Officer Sale −328 $1.61 $526 1,071,388
2022-12-29 Jacobs Bette Director Sale −4,366 $1.61 $7K 31,221
2022-12-29 Dritschilo Peter President and COO Sale −3,820 $1.61 $6K 6,560
2022-12-29 Vander Hoek Michael Chief Financial Officer Sale −2,243 $1.61 $4K 3,852
2022-09-02 Adkins William Former Director Other acquisition · WARRANTS (right to buy) +138,889 138,889

Page 2 of 2 · 35 trades